These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 21933348

  • 1. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R.
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M, Sand M, BEGONIA trial investigators.
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [Abstract] [Full Text] [Related]

  • 3. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR, Komer L, Katz M, Moreau M, Kimura T, Garcia M, Wunderlich G, Pyke R, VIOLET Trial Investigators.
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z, Yang D, Yu L, Cui Y.
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M, Sand M.
    Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M, Lesko L, Pyke R, DAISY trial investigators.
    J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
    [Abstract] [Full Text] [Related]

  • 7. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA, Derogatis L, Portman D, Brown L, Yuan J, Kissling R.
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [Abstract] [Full Text] [Related]

  • 8. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.
    Kornstein SG, Simon JA, Apfel SC, Yuan J, Barbour KA, Kissling R.
    J Womens Health (Larchmt); 2017 Nov; 26(11):1161-1168. PubMed ID: 28817365
    [Abstract] [Full Text] [Related]

  • 9. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA, Thorp J, Millheiser L.
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [Abstract] [Full Text] [Related]

  • 10. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C, Simon JA, Taylor LV, Kimura T, Lesko LM, SUNFLOWER study investigators.
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [Abstract] [Full Text] [Related]

  • 11. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.
    Fisher WA, Pyke RE.
    Sex Med Rev; 2017 Oct; 5(4):445-460. PubMed ID: 28666836
    [Abstract] [Full Text] [Related]

  • 12. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ, Brown L, Yuan J, Kissling R, Kingsberg SA.
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
    Kennedy S.
    J Sex Med; 2010 Oct; 7(10):3449-59. PubMed ID: 20646181
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ET.
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH, Dennerstein L, Pyke R, Sand M.
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [Abstract] [Full Text] [Related]

  • 18. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
    Fabre LF, Brown CS, Smith LC, Derogatis LR.
    J Sex Med; 2011 May; 8(5):1411-9. PubMed ID: 21324094
    [Abstract] [Full Text] [Related]

  • 19. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I, Simon JA.
    Expert Opin Pharmacother; 2015 May; 16(16):2523-9. PubMed ID: 26395164
    [Abstract] [Full Text] [Related]

  • 20. Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin.
    Simon JA, Clayton AH, Kim NN, Patel S.
    Sex Med; 2022 Feb; 10(1):100476. PubMed ID: 34999484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.